CEMIP and cancer: Since KIAA1199 has been found to be highly expressed in human cancers as compared to normal tissues, we examined whether methylation of the KIAA1199 promoter is a possible mechanism controlling its expression in human cancer tissues and in aggressive cancer cell lines.